AAAAAA

   
Results: 1-12 |
Results: 12
Monitoring renal function in obese patients with Type 2 diabetes mellitus in daily practice
Authors: van de Ree, MA Christiaan, G Huisman, MV van der Vijver, JCM Meinders, AE
Citation: Ma. Van De Ree et al., Monitoring renal function in obese patients with Type 2 diabetes mellitus in daily practice, DIABET NUTR, 14(2), 2001, pp. 66-70
The effect of aggressive versus standard lipid lowering by atorvastatin ondiabetic dyslipidemia - The DALI Study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia
Authors: Berkplanken, I Hoogerbrugge, N Jansen, H Jansen, H Princen, HMG Huisman, MV van de Ree, MA Stolk, RP van Venrooij, FV Banga, JD Dallinga-Thie, G van Venrooij, FV
Citation: I. Berkplanken et al., The effect of aggressive versus standard lipid lowering by atorvastatin ondiabetic dyslipidemia - The DALI Study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia, DIABET CARE, 24(8), 2001, pp. 1335-1341
Reduction in thrombus extension and clinical end points in patients after initial treatment for deep vein thrombosis with the fixed-dose body weight-independent low molecular weight heparin certoparin
Authors: Harenberg, J Huisman, MV Tolle, AR Breddin, HK Kirchmaier, CM
Citation: J. Harenberg et al., Reduction in thrombus extension and clinical end points in patients after initial treatment for deep vein thrombosis with the fixed-dose body weight-independent low molecular weight heparin certoparin, SEM THROMB, 27(5), 2001, pp. 513-518
Use of a new monoclonal antibody-based enzyme immunoassay for soluble fibrin to exclude pulmonary embolism
Authors: Mac Gillavry, MR Sanson, BJ de Monye, W Lijmer, JG Huisman, MV Buller, HR Nieuwenhuizen, W Brandjes, DPM
Citation: Mr. Mac Gillavry et al., Use of a new monoclonal antibody-based enzyme immunoassay for soluble fibrin to exclude pulmonary embolism, THROMB HAEM, 84(3), 2000, pp. 474-477
Clinical evaluation of a monoclonal antibody-based enzyme immunoassay for fibrin degradation products in patients with clinically suspected pulmonaryembolism
Authors: Mac Gillavry, MR de Monye, W Lijmer, JG Nieuwenhuizen, W Buller, HR Huisman, MV Brandjes, DPM
Citation: Mr. Mac Gillavry et al., Clinical evaluation of a monoclonal antibody-based enzyme immunoassay for fibrin degradation products in patients with clinically suspected pulmonaryembolism, THROMB HAEM, 83(6), 2000, pp. 892-895
Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis
Authors: Harenberg, J Schmidt, JA Koppenhagen, K Tolle, A Huisman, MV Buller, HR
Citation: J. Harenberg et al., Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis, THROMB HAEM, 83(5), 2000, pp. 652-656
Suspected pulmonary embolism: Prevalence and anatomic distribution in 487 consecutive patients
Authors: de Monye, W van Strijen, MJL Huisman, MV Kieft, GJ Pattynama, PMT
Citation: W. De Monye et al., Suspected pulmonary embolism: Prevalence and anatomic distribution in 487 consecutive patients, RADIOLOGY, 215(1), 2000, pp. 184-188
Treatment of proximal deep vein thrombosis with a novel synthetic compound(SR90107A/ORG31540) with pure anti-factor Xa activity - A phase II evaluation
Authors: Buller, HR Cariou, R Gallus, A Gent, M Ginsberg, J Prins, MH Lensing, A Levi, M Nurmohammed, N Hirsh, J Roberts, R ten Cate, JW Decousus, H Mismetti, P Buchmuller, A Charlet, V Viallon, A van der Meer, J Meinardi, JR Meijer, K Piovella, F Barone, M Beltrametti, C Serafini, S Kraaijenhagen, RA Koopman, MMW Jagt, HHT Muller, MBR Kooy, MV Nauta, S Gallus, AS Coghlan, D Rich, C Prandoni, P Scudeller, A Scarano, L Girolami, A Baker, R Tan, E Cooney, J Eikelboom, J Ninet, J Dolmazon, C Madoux, MHG Coppere, B Nenci, GG Agnelli, G Falcinelli, F Morini, M d'Angelo, A Crippa, L d'Angelo, SV Chong, B Chestreman, C Malvin, J Eisbacher, M MacGillavry, MR Brandjes, DPM Beaumont, JFM Olmos, RAV Turpie, AGG Johnson, J Nowacki, B Anderson, D Pleasance, S Mitchell, M Ockelford, P Bennett, A Jones, R Porteous, F Weitz, J Kearon, C Simonneau, G Parent, F Douketis, J Schnurr, T Hainaut, P Petit, B Jaumotte, C Huisman, MV van Poelgeest, MIE Meinders, AE van Oostayen, JA Beer, J Lugli, A Pederiva, S Ginsberg, J Brill-Edwards, P Stevens, P Bassand, JP Seronde, MF Kassis, J Fortin, M Faivre, R Petiteau, PY Verhaeghe, R Wells, P Lewandowski, B Touchie, D Banga, JD Hartmann, IJC Zeguers, VJM Desjardins, L Villeneuve, J Cote, J Bounameaux, H Cirafici, P Demers, C van der Heul, C Kruip, M
Citation: Hr. Buller et al., Treatment of proximal deep vein thrombosis with a novel synthetic compound(SR90107A/ORG31540) with pure anti-factor Xa activity - A phase II evaluation, CIRCULATION, 102(22), 2000, pp. 2726-2731
Frequency of major hemorrhage in patients treated with unfractionated intravenous heparin for deep venous thrombosis or pulmonary embolism - A study in routine clinical practice
Authors: Zidane, M Schram, MT Planken, EW Molendijk, WH Rosendaal, FR van der Meer, FJM Huisman, MV
Citation: M. Zidane et al., Frequency of major hemorrhage in patients treated with unfractionated intravenous heparin for deep venous thrombosis or pulmonary embolism - A study in routine clinical practice, ARCH IN MED, 160(15), 2000, pp. 2369-2373
Incidence of venous thromboembolism in families with inherited thrombophilia
Authors: Simioni, P Sanson, BJ Prandoni, P Tormene, D Friederich, PW Girolami, B Gavasso, S Huisman, MV Buller, HR ten Cate, JW Girolami, A Prins, MH
Citation: P. Simioni et al., Incidence of venous thromboembolism in families with inherited thrombophilia, THROMB HAEM, 81(2), 1999, pp. 198-202
Observer dependency of the simplified D-dimer assay in 81 consecutive patients with suspected pulmonary embolism
Authors: de Monye, W Huisman, MV Pattynama, PMT
Citation: W. De Monye et al., Observer dependency of the simplified D-dimer assay in 81 consecutive patients with suspected pulmonary embolism, THROMB RES, 96(4), 1999, pp. 293-298
The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: A prospective cohort study
Authors: Sanson, BJ Simioni, P Tormene, D Moia, M Friederich, PW Huisman, MV Prandoni, P Bura, A Rejto, L Wells, P Mannucci, PM Girolami, A Buller, HR Prins, MH
Citation: Bj. Sanson et al., The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: A prospective cohort study, BLOOD, 94(11), 1999, pp. 3702-3706
Risultati: 1-12 |